Use of a CB1 antagonist for treating side effects and negative symptoms of schizophrenia
The present invention discloses and claims a method of treating cognition deficits in a patient suffering from schizophrenia by administering to said patient a therapeutically effective amount of a CB1 receptor antagonist as described herein. In another aspect, this invention also discloses and clai...
Saved in:
| Main Authors | , , , , |
|---|---|
| Format | Patent |
| Language | Chinese English |
| Published |
16.01.2008
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention discloses and claims a method of treating cognition deficits in a patient suffering from schizophrenia by administering to said patient a therapeutically effective amount of a CB1 receptor antagonist as described herein. In another aspect, this invention also discloses and claims a combination of one or more CB1 receptor antagonists and of one or more antipsychotic agents useful in the treatment of psychiatric disorders. The combination of this invention provides synergistic results in that the combination improves positive and negative symptoms of schizophrenia, weight gain and catalepsy. |
|---|---|
| AbstractList | The present invention discloses and claims a method of treating cognition deficits in a patient suffering from schizophrenia by administering to said patient a therapeutically effective amount of a CB1 receptor antagonist as described herein. In another aspect, this invention also discloses and claims a combination of one or more CB1 receptor antagonists and of one or more antipsychotic agents useful in the treatment of psychiatric disorders. The combination of this invention provides synergistic results in that the combination improves positive and negative symptoms of schizophrenia, weight gain and catalepsy. |
| Author | ROGACKI, NANCY SENYAH, YAW BOROWSKY, BETH BLACK, MARK DAVID STEVENS, RACHEL |
| Author_xml | – fullname: BOROWSKY, BETH – fullname: BLACK, MARK DAVID – fullname: SENYAH, YAW – fullname: ROGACKI, NANCY – fullname: STEVENS, RACHEL |
| BookMark | eNqNjDsKwkAQQLfQwt8dxgMI0TSx1KB4gIh2YUhmNwtmZskMgp7eCB7A6hXv8eZuwsI0c_erEogHhPK4BWTDIBzVwMsANhBa5AAaWwLynhrTMWqBKYzmSaCvPpn0-n1o08W3pG4gjrh0U48PpdWPC7c-n6rysqEkNWnChpisrm67LCuyvMj3h_yf5gNhSzus |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | TW200803839A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_TW200803839A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 14:57:35 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | Chinese English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_TW200803839A3 |
| Notes | Application Number: TW200695145876 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080116&DB=EPODOC&CC=TW&NR=200803839A |
| ParticipantIDs | epo_espacenet_TW200803839A |
| PublicationCentury | 2000 |
| PublicationDate | 20080116 |
| PublicationDateYYYYMMDD | 2008-01-16 |
| PublicationDate_xml | – month: 01 year: 2008 text: 20080116 day: 16 |
| PublicationDecade | 2000 |
| PublicationYear | 2008 |
| RelatedCompanies | AVENTIS PHARMACEUTICALS INC |
| RelatedCompanies_xml | – name: AVENTIS PHARMACEUTICALS INC |
| Score | 2.7975242 |
| Snippet | The present invention discloses and claims a method of treating cognition deficits in a patient suffering from schizophrenia by administering to said patient a... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | Use of a CB1 antagonist for treating side effects and negative symptoms of schizophrenia |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080116&DB=EPODOC&locale=&CC=TW&NR=200803839A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6LzgwjSt6JjmbYPQ2y7MYR9IJ3r20ibdiqsLaYi-td7l61uL_oWknAkB5fL5X75HcAVcZqESathSmFHJudcmpaIEtO-k7JhWYLzhDK6_cFtb8wfg1ZQgbfyL4zmCf3U5IhoURHae6HP63z1iOVpbKW6Dl-xK7vv-m3PKKNji_IKhue0O6OhN3QN1237E2PwtBjDaMx-2IBNukYTz37n2aFfKfm6S-nuwdYIpaXFPlS-X2qw45aV12qw3V8mvLG5tD11AMFYxSxLmGCu02CoEDHLiPaW4bWTabw4eiFG1TfZEqSBkyRL45nm9mbqa54X2VyRDLUOtTuEy27Hd3smLnH6q4-pP1ntpnkE1TRL42NgkbhpJlwQxaDkcYShbRRSWlByGVNkdwL1v-XU_xs8hd0FTIJqSp9BtXj_iM_RFxfhhVbiD5AojxY |
| link.rule.ids | 230,309,786,891,25594,76903 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT8IwEL4gGvFNUYP4qyZmb4sSimwPi3EbBJUNYobwRrp1Q03YFjdj9K_3Wpjwom9Nu1zWS27Xb_f1O4BLoWniR62GypkeqJRSrmosiFS9zXlD0xilkajoOu5Nb0QfJq1JCd6KuzBSJ_RTiiNiRAUY77n8Xqern1i25FZmV_4rTiW3Xc-wlQIda6KuoNim0RkO7IGlWJbhjRX3abGGaEy_24DNNkJCCZWeTXErJV1PKd1d2BqitTjfg9L3SxUqVtF5rQrbzrLgjcNl7GX7MBllIUkiwohlNgg6hM0SIXtL8NhJJF8csxAR3TfJkqSBD3EShzOp7U2yr3maJ_NM2MjWqXYHcNHteFZPxVec_vpj6o1Xu2keQjlO4rAGJGDXzYgyITHIaRggtA18URbklIcC2R1B_W879f8Wz6HS85z-tH_vPh7DzoIyIfpLn0A5f_8ITzEv5_6ZdOgPZl2SAA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Use+of+a+CB1+antagonist+for+treating+side+effects+and+negative+symptoms+of+schizophrenia&rft.inventor=BOROWSKY%2C+BETH&rft.inventor=BLACK%2C+MARK+DAVID&rft.inventor=SENYAH%2C+YAW&rft.inventor=ROGACKI%2C+NANCY&rft.inventor=STEVENS%2C+RACHEL&rft.date=2008-01-16&rft.externalDBID=A&rft.externalDocID=TW200803839A |